MedTrace Logo

Effect of Cranberry Extract on Infections in Burn Patients

NCT01225107 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-10-13

No results posted yet for this study

Summary

Bacterial infections are a common complication in patients suffering from burns. These infections can cause significant morbidity and often mortality. Antimicrobial resistance coupled with the prevalence of burn-related infections warrants the identification of alternative substances in the treatment of burn-related infections. The cranberry has been examined as a potential agent in the prevention of other types of infections and it appears to have anti-adherence effects on bacteria. In addition, the cranberry has demonstrated general inhibitory effects against some types of bacteria suggesting that it may be a useful agent in the prevention of bacterial infections in burn patients. The purpose of the present study is to investigate the effect of cranberry extract on the incidence of infections in burn patients.

Conditions

  • Burn

Interventions

DIETARY_SUPPLEMENT

Cranberry Extract

500mg TID

DRUG

Inert Placebo Capsule

Inert substance, 3 times per day in capsule form

Sponsors & Collaborators

  • Saint Elizabeth Regional Medical Center

    lead OTHER

Principal Investigators

  • David W Voigt, M.D. · Saint Elizabeth Regional Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01225107 on ClinicalTrials.gov